43 related articles for article (PubMed ID: 4013343)
1. Androgen receptors, serum androgen levels and survival of breast cancer patients.
Langer M; Kubista E; Schemper M; Spona J
Arch Gynecol Obstet; 1990; 247(4):203-9. PubMed ID: 2221994
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
3. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
[TBL] [Abstract][Full Text] [Related]
4. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
[TBL] [Abstract][Full Text] [Related]
5. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
6. [Steroid hormone receptors in breast cancer].
Nomura Y
Rinsho Byori; 1990 Jan; 38(1):26-30. PubMed ID: 2308219
[TBL] [Abstract][Full Text] [Related]
7. [Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].
Zielinski CC; Kuzmits R; Kubista E; Salzer H; Staffen A; Aiginger P; Spona J
Wien Klin Wochenschr; 1985 May; 97(11):493-7. PubMed ID: 4013343
[TBL] [Abstract][Full Text] [Related]
8. Current strategies in operable breast cancer.
Deckers PJ
Hosp Pract (Off Ed); 1987 Jan; 22(1A):41-9, 53-4, 59-68. PubMed ID: 3100553
[No Abstract] [Full Text] [Related]
9. [Prognostic value of hormonal receptors].
Paradiso A; De Lena M
Pathologica; 1987; 79(1059-1060):165-76. PubMed ID: 3327042
[No Abstract] [Full Text] [Related]
10. Treatment of early-stage breast cancer. Many questions, a few answers.
Laughlin EH
Ala Med; 1991 Apr; 60(10):10-4. PubMed ID: 1862754
[No Abstract] [Full Text] [Related]
11. The present status of the adjuvant endocrine treatment.
Jonat W; Maass H
J Steroid Biochem; 1987; 27(1-3):499-502. PubMed ID: 3320540
[TBL] [Abstract][Full Text] [Related]
12. [Estrogen and progesterone receptors in breast cancer].
Cohen Y; Borovik R
Harefuah; 1985 Dec; 109(11):350-2. PubMed ID: 3912300
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
